ルベル・インターナショナル病院
| トルコ | オーストリア | スペイン | |
| 結腸切除術 | から $6,912 | から $22,000 | から $18,000 |
| 大腸癌に対する放射線療法 | から $7,000 | から $12,000 | から $10,000 |
| 乳癌化学療法 | から $1,200 | から $15,000 | から $3,500 |
この医師は腹膜癌症に特化した腫瘍外科医であり、2019年からTeknon Oncology InstituteのCarcinomatosis Surgical Groupの一員です。彼女はワシントン病院センターでPaul Sugarbaker教授の下で専門を修了し、American Board of Surgeryの認定を受けています。<\/p>
彼女はAmerican College of SurgeonsやSociety of Surgical Oncologyなどのいくつかの著名な学会のメンバーです。彼女の学術的な役割には、Inova Fairfax Hospitalの研究ディレクターや、Virginia Commonwealth UniversityおよびGeorgetown Universityでの准教授職が含まれています。<\/p>
Primary surgical options for sigmoid colon adenocarcinoma in Spain include laparoscopic or robotic sigmoidectomy and oncological resection. Surgeons remove the sigmoid colon segment along with its blood supply and lymph nodes. Minimally invasive techniques are standard in Joint Commission International-accredited centers in Barcelona and Madrid.
Bookimed Expert Insight: Spanish surgical centers show high specialization in complex oncological cases. Dr. Antonio de Lacy Fortuny at Hospital Quiron Barcelona has performed over 15,000 procedures. He founded laparoscopic colon surgery techniques used worldwide. High-volume centers like Hospital Quiron Barcelona and Clinica Universidad de Navarra serve over 40,000 patients annually. This volume correlates with high surgical expertise in minimally invasive colorectal oncology.
Patient Consensus: Patients are often concerned about the possibility of a temporary stoma bag. They emphasize asking surgeons about clear margins and the total number of lymph nodes removed.
Spanish hospitals treat sigmoid adenocarcinoma using standard Spanish Society of Medical Oncology protocols. Primary regimens include CAPOX and FOLFOX for localized cases. Advanced stages require targeted biologics like cetuximab or panitumumab. Treatment selection depends on molecular profile and tumor location within the left-sided sigmoid colon.
Bookimed Expert Insight: Spanish oncology networks like HM Hospitales and Quironsalud are unique for their high patient volumes and integrated research units. Hospital HM Nou Delfos alone serves 400,000 patients annually. This massive data pool allows Spanish centers to offer specialized clinical trials often unavailable in smaller medical systems. Patients should ask about trial eligibility at centers like Quironsalud Madrid, which maintains dedicated research teams for cancer treatments.
Patient Consensus: Patients note that Spanish care mirrors standard Western guidelines, focusing on FOLFOX for early stages. Many emphasize the importance of managing oxaliplatin-related neuropathy and checking if oral capecitabine is a viable, convenient option.
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) combined with cytoreductive surgery is available in Spain for advanced sigmoid cancer with peritoneal spread. Specialized JCI-accredited centers in Barcelona and Madrid perform these complex procedures. Spanish surgical oncology teams often utilize Mitomycin C-based regimens to prevent cancer recurrence.
Bookimed Expert Insight: Spanish oncology centers represent a high-value alternative to other European hubs due to their specialized research focus. For example, Dr. José Manuel Richart Aznar has chaired departments and published research in JAMA Surgery regarding these protocols. Patients often choose Barcelona because centers there, like Hospital Quiron Barcelona, collaborate with top American oncology institutes to refine their surgical outcomes.
Patient Consensus: Patients note that HIPEC is a highly selective procedure that requires a specialist referral from a major center. They emphasize that suitability depends entirely on whether the cancer is confined to the abdominal lining.
Personalized oncology for sigmoid adenocarcinoma is widely available in Spain. Clinics utilize molecular testing and immunotherapy based on European Society for Medical Oncology guidelines. Advanced facilities perform next-generation sequencing to identify KRAS and BRAF mutations. These markers determine if targeted therapies or immunotherapy are appropriate.
Bookimed Expert Insight: Spain stands out because private networks like Quironsalud and HM Hospitales integrate clinical research directly into patient care. This allows patients to access experimental biological regimens that may not be available in standard protocols elsewhere. Clinics like Hospital Quiron Barcelona even collaborate with elite American institutes to refine these precision medicine pathways.
Patient Consensus: Patients note that confirming tumor markers early is vital for receiving targeted therapy. They often emphasize that secondary molecular sequencing at larger centers can reveal more treatment options than basic hospital tests.
Leading Spanish hospitals like Centro Médico Teknon and Hospital Quirónsalud Barcelona provide internationally recognized care for sigmoid adenocarcinoma. These JCI-accredited centers utilize robotic-assisted resections and targeted molecular therapies. Expert surgeons in Madrid and Barcelona follow multidisciplinary protocols to ensure high survival rates and precise diagnostic staging.
Bookimed Expert Insight: Spanish oncology centers like Centro Médico Teknon integrate surgical research directors with international training to manage complex cases. Dr. Lana Bijelic brings expertise in peritoneal carcinomatosis directly to their multidisciplinary teams. This academic integration often leads to more comprehensive treatment plans for advanced stage cancers compared to standard clinical settings.
Patient Consensus: Patients emphasize finding a center where surgeons perform 1,000+ minimally invasive procedures annually to improve outcomes. They also recommend ensuring the hospital has a multidisciplinary tumor board to review pathology and molecular profiling before starting treatment.
Recognized Spanish surgeons for sigmoid adenocarcinoma include world leaders in minimally invasive colorectal surgery. Specialists like Dr. Antonio de Lacy Fortuny at Hospital Quiron Barcelona and Dr. Lana Bijelic at Centro Médico Teknon utilize robotic-assisted resections. These JCI-accredited centers ensure high-precision tumor removal and faster recovery times.
Bookimed Expert Insight: While patients often focus on individual surgeons, Spain's high-volume hospitals like Centro Médico Teknon offer a significant structural advantage. This clinic holds over 7 JCI accreditations and serves 10,000+ patients annually. Choosing a facility with this volume ensures your case undergoes a multidisciplinary review by a full oncology team.
Patient Consensus: Patients emphasize finding a dedicated colorectal focus rather than a general surgeon. They note the comfort of having pathology and stoma care available within the same Spanish hospital.
Spanish private hospitals provide extensive language support through dedicated international patient departments and multilingual medical coordinators. Centers like Centro Medico Teknon and Hospital Quiron Barcelona offer personalized assistance to ensure clear communication during complex oncology diagnostics and surgical procedures.
Bookimed Expert Insight: Data shows a clear communication advantage in private centers like Clinica Universidad de Navarra, which has treated patients from 70 countries. While public hospitals rely on phone interpretation, top-tier private facilities integrate translation into the care pathway. For complex cases like sigmoid adenocarcinoma, this ensures critical pathology and surgical consent details are perfectly understood.
Patient Consensus: Patients note that while oncologists often speak English, administrative documents and discharge instructions frequently remain in Spanish. Many recommend having a bilingual contact for consent discussions and carefully reviewing written medication directions before leaving the hospital.